AMN Healthcare downgraded by BofA Securities with a new price target
$AMN
Professional Services
Consumer Discretionary
BofA Securities downgraded AMN Healthcare from Buy to Neutral and set a new price target of $104.00 from $112.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/8/2024 | Outperform → Mkt Perform | William Blair | |
| 10/7/2024 | $65.00 → $48.00 | Neutral → Underperform | BofA Securities |
| 12/6/2023 | $85.00 | Mkt Outperform | JMP Securities |
| 11/3/2023 | $115.00 → $70.00 | Buy → Hold | Jefferies |
| 11/3/2023 | Buy → Hold | The Benchmark Company | |
| 8/4/2023 | $112.00 → $104.00 | Buy → Neutral | BofA Securities |
| 2/18/2022 | $140.00 → $170.00 | Buy | Jefferies |
| 2/18/2022 | $125.00 → $140.00 | Buy | Benchmark |
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031. The 2031 Notes will bear an interest rate of 6.500% per annum and will be issued at 100.0% of their face value. The 2031 Notes will be guaranteed by the Company's affiliates that guarantee the Company's credit facilities. The Company intends to use the proceeds from the private offering, together with cash on hand and borrowings under a new revolving facility that the Company intends to enter into substanti
DALLAS, Sept. 22, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), announced today that its wholly owned subsidiary, AMN Healthcare, Inc., intends to make a private offering of $400.0 million aggregate principal amount of senior unsecured notes due 2031, subject to market and other conditions. The 2031 Notes will be guaranteed by the Company's affiliates that guarantee the Company's credit facilities. The Company intends to use the proceeds from the private offering, together with cash on hand and borrowings under the Company's secured revolving credit facility, (i) to redeem all of the $500.0 million aggregate principal amount of its 4.625% senior unsecured notes due 20
Quarterly revenue of $658 million and Adjusted EBITDA of $58.3 million; GAAP loss of ($3.02)/share and adjusted EPS of $0.30 DALLAS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q2 2025% Change Q2 2024YTD June 30, 2025% Change YTD June 30, 2024Revenue$658.2 (11%)$1,347.7 (14%)Gross profit$196.4 (15%)$394.5 (19%)Net loss($116.2)nm($117.3)nmDiluted loss per share($3.02)nm($3.06)nmAdjusted diluted EPS*$0.30 (69%)$
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
4 - AMN HEALTHCARE SERVICES INC (0001142750) (Issuer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
8-K - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
10-Q - AMN HEALTHCARE SERVICES INC (0001142750) (Filer)
William Blair downgraded AMN Healthcare from Outperform to Mkt Perform
BofA Securities downgraded AMN Healthcare from Neutral to Underperform and set a new price target of $48.00 from $65.00 previously
JMP Securities initiated coverage of AMN Healthcare with a rating of Mkt Outperform and set a new price target of $85.00
WAYNE, Pa. and CHICAGO, Aug. 7, 2025 /PRNewswire/ -- O.R. Staffing Solutions (ORSS), an Argosy Healthcare Partners (AHP) portfolio company, is pleased to announce the appointment of Brent Bormaster as CEO. In addition, Mark Smith and Jerick Henley have joined the company's Board as Executive Chairman and Director, respectively. Brent, Mark, Jerick, and Paul Barrett, AHP's Managing Partner, previously worked together in scaling and exiting American Health Staffing Group (AHSG). ORSS provides workforce solutions for operating rooms in acute care hospitals and ambulatory surgery centers (ASCs).
DALLAS, Oct. 31, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations, today announced the appointment of Tomya Watt as Chief People Officer effective January 13, 2025. With more than two decades of strategic and operational experience in healthcare and talent solutions, Ms. Watt is well-equipped to guide the company's human resources function into a new era of sustainable growth. "We are thrilled to welcome Tomya Watt to AMN Healthcare," said Cary Grace, AMN Healthcare's President and CEO. "Our exceptional team and culture distinguish us in the industry. Tomya's visionary leadership and extensive expertise
DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN) ("AMN" or "the Company"), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced that Brian Scott has been appointed Chief Financial Officer and Chief Operating Officer, effective November 21, 2024. In this role, Mr. Scott will be responsible for AMN's finance and enterprise operating functions as the Company continues to evolve its model to be more automated and scaled. Mr. Scott is returning to AMN, where he previously held a variety of roles of increasing responsibility in finance, strategy and accounting over his 17-year tenure, includin
Quarterly revenue of $658 million and Adjusted EBITDA of $58.3 million; GAAP loss of ($3.02)/share and adjusted EPS of $0.30 DALLAS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its second quarter 2025 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. Q2 2025% Change Q2 2024YTD June 30, 2025% Change YTD June 30, 2024Revenue$658.2 (11%)$1,347.7 (14%)Gross profit$196.4 (15%)$394.5 (19%)Net loss($116.2)nm($117.3)nmDiluted loss per share($3.02)nm($3.06)nmAdjusted diluted EPS*$0.30 (69%)$
DALLAS, July 10, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE:AMN), has scheduled a conference call to discuss its second quarter 2025 financial results and third quarter 2025 outlook on Thursday, August 7, 2025, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail add
Strengthening symplr's commitment to helping providers optimize staffing, operations, and outcomes HOUSTON, July 2, 2025 /PRNewswire/ -- symplr®, a leading provider of enterprise healthcare operations software backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and Charlesbank Capital Partners LLC (together with its affiliates, "Charlesbank"), has acquired the Smart Square® scheduling software from AMN Healthcare (NYSE:AMN). This strategic acquisition strengthens symplr's position in healthcare workforce and operations management and further bo
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)
SC 13G/A - AMN HEALTHCARE SERVICES INC (0001142750) (Subject)